Diffuse gliomas with <i>FGFR3‐TACC3</i> fusion have characteristic histopathological and molecular features
Franck Bielle(Centre National de la Recherche Scientifique), Karima Mokhtari(Inserm), Audrey Rousseau(Pitié-Salpêtrière Hospital), Claude‐Alain Maurage(Centre Hospitalier Universitaire de Lille), David Meyronet(Université Claude Bernard Lyon 1), Marine Giry(Centre National de la Recherche Scientifique), Chiara Villa(Centre National de la Recherche Scientifique), Anna Lasorella(Istituto Tumori Bari), Marc Sanson(Centre National de la Recherche Scientifique), Emmanuelle Uro‐Coste(Institut universitaire du cancer de Toulouse Oncopole), Antonio Iavarone(University of Miami), Anna Luisa Di Stefano(Hôpital Foch), Alberto Pïcca(Centre National de la Recherche Scientifique), Dominique Figarella‐Branger(Inserm), Michèle Bernier(Hôpital Foch), Yohann Schmitt(Centre National de la Recherche Scientifique)
Cited by 69
Related Papers
Oncogenic Signaling Pathways in The Cancer Genome Atlas
|Cell|2018|3.4k
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
|Cell|2016|2.4k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
|Genes & Development|1995|963